Multiple high dose tDCS sessions produces perceived improvement and stabilisation in a person with a MAPT gene, presenting clinically as semantic variant primary progressive aphasia with severe cognitive impairment

Publication date: Available online 6 February 2021Source: Brain StimulationAuthor(s): C. Roncero, A. Popov, H. Chertkow
Source: Brain Stimulation - Category: Neurology Source Type: research
More News: Aphasia | Brain | Genetics | Neurology